中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
2期
21-22
,共2页
阿维A%复发性尖锐湿疣%临床效果%安全性
阿維A%複髮性尖銳濕疣%臨床效果%安全性
아유A%복발성첨예습우%림상효과%안전성
Avi A%Recurrent genital warts%Clinical efficacy%Security
目的:探讨阿维A辅助治疗复发性尖锐湿疣临床效果及安全性。方法选取本院近年来收治复发性尖锐湿疣患者70例,随机分为对照组和阿维A组,每组各35例;其中对照组采用常规对症治疗;阿维A组在对照组治疗基础上,加用阿维A口服治疗;比较两组患者临床复发率,治疗前后血清细胞因子水平及不良反应发生率等。结果阿维A组患者治疗后1个月、3个月及6个月临床复发率均显著低于对照组( P<0.05);对照组和阿维A组患者治疗后IL-4、IL-10及IFN-γ等细胞因子水平均显著优于治疗前,且阿维A组患者细胞因子水平改善程度均显著优于于对照组( P<0.05);阿维A组患者皮肤不适及口干发生率均显著高于对照组,但皮肤溃烂发生率显著低于对照组(P<0.05)。结论阿维A辅助治疗复发性尖锐湿疣可有效降低临床复发风险,改善机体细胞因子水平,提高机体免疫力,且无严重不良反应。
目的:探討阿維A輔助治療複髮性尖銳濕疣臨床效果及安全性。方法選取本院近年來收治複髮性尖銳濕疣患者70例,隨機分為對照組和阿維A組,每組各35例;其中對照組採用常規對癥治療;阿維A組在對照組治療基礎上,加用阿維A口服治療;比較兩組患者臨床複髮率,治療前後血清細胞因子水平及不良反應髮生率等。結果阿維A組患者治療後1箇月、3箇月及6箇月臨床複髮率均顯著低于對照組( P<0.05);對照組和阿維A組患者治療後IL-4、IL-10及IFN-γ等細胞因子水平均顯著優于治療前,且阿維A組患者細胞因子水平改善程度均顯著優于于對照組( P<0.05);阿維A組患者皮膚不適及口榦髮生率均顯著高于對照組,但皮膚潰爛髮生率顯著低于對照組(P<0.05)。結論阿維A輔助治療複髮性尖銳濕疣可有效降低臨床複髮風險,改善機體細胞因子水平,提高機體免疫力,且無嚴重不良反應。
목적:탐토아유A보조치료복발성첨예습우림상효과급안전성。방법선취본원근년래수치복발성첨예습우환자70례,수궤분위대조조화아유A조,매조각35례;기중대조조채용상규대증치료;아유A조재대조조치료기출상,가용아유A구복치료;비교량조환자림상복발솔,치료전후혈청세포인자수평급불량반응발생솔등。결과아유A조환자치료후1개월、3개월급6개월림상복발솔균현저저우대조조( P<0.05);대조조화아유A조환자치료후IL-4、IL-10급IFN-γ등세포인자수평균현저우우치료전,차아유A조환자세포인자수평개선정도균현저우우우대조조( P<0.05);아유A조환자피부불괄급구간발생솔균현저고우대조조,단피부궤란발생솔현저저우대조조(P<0.05)。결론아유A보조치료복발성첨예습우가유효강저림상복발풍험,개선궤체세포인자수평,제고궤체면역력,차무엄중불량반응。
Objective To investigate clinical efficacy and security of Avi A associated treatment on re -current genital warts .Methods 70 patients with recurrent genital warts were chosen in recent years in our hos-pital and randomly divided into two groups including control group (35 patients) with conventional symptomatic treatment and Avi A group (35 patients) with Avi A orally treatment;and the clinical relapse rate , cytokines levels in serum before and after treatment and incidence of adverse reaction of both groups were compared . Results The clinical relapse rate of Avi A group was lower than control group in 1 month, 3 months and 6 months after treatment(P<0.05).The cytokines levels in serum after treatment of both groups was significant better than before treatment(P<0.05).The improving degree of Avi A group after treatnemtn was significant higher than control group ( P<0.05 ) .The incidence of skin irritation , dry mouth of Avi A group was higher than control group(P<0.05).The incidence of skin ulcers of Avi A group was lower than control group (P<0.05).Conclusion Avi A associated treatment on recurrent genital warts can efficiently reduce the risk of clinical recurrence , improve cytokines levels , higher body immunity , and has no serious adverse reactions .